Press Release Cardiawave confirms the safety of Valvosoft®, its non-invasive ultrasound treatment for aortic stenosis. Jun 14, 2022 HeleneCardiawave 0
Press Release Cardiawave announces the authorization by the French National Agency for the Safety of Medicines and Health Products (ANSM) to proceed with a new clinical study in France. May 2, 2022 HeleneCardiawave 0
Press Release Cardiawave announces the success of its clinical trial to treat aortic stenosis. Mar 22, 2022 DanielCardiawave 0
Press Release Cardiawave confirms the safety of Valvosoft®, its non-invasive ultrasound treatment for aortic stenosis. Jun 14, 2022 HeleneCardiawave 0
Press Release Cardiawave announces the authorization by the French National Agency for the Safety of Medicines and Health Products (ANSM) to proceed with a new clinical study in France. May 2, 2022 HeleneCardiawave 0
Press Release Cardiawave announces the success of its clinical trial to treat aortic stenosis. Mar 22, 2022 DanielCardiawave 0
